125 related articles for article (PubMed ID: 29981527)
1. Impact of hepatocellular carcinoma aetiology and liver function on the benefit of surveillance: A novel approach for the adjustment of lead-time bias.
Toyoda H; Kumada T; Tada T; Mizuno K; Hiraoka A; Tsuji K; Ishikawa T; Akita T; Tanaka J
Liver Int; 2018 Dec; 38(12):2260-2268. PubMed ID: 29981527
[TBL] [Abstract][Full Text] [Related]
2. Tumor Volume Doubling Time as a Dynamic Prognostic Marker for Patients with Hepatocellular Carcinoma.
Kim JK; Kim HD; Jun MJ; Yun SC; Shim JH; Lee HC; Lee D; An J; Lim YS; Chung YH; Lee YS; Kim KM
Dig Dis Sci; 2017 Oct; 62(10):2923-2931. PubMed ID: 28815349
[TBL] [Abstract][Full Text] [Related]
3. Hepatocellular carcinoma tumour volume doubling time: a systematic review and meta-analysis.
Nathani P; Gopal P; Rich N; Yopp A; Yokoo T; John B; Marrero J; Parikh N; Singal AG
Gut; 2021 Feb; 70(2):401-407. PubMed ID: 32398224
[TBL] [Abstract][Full Text] [Related]
4. Estimation of lead-time bias and its impact on the outcome of surveillance for the early diagnosis of hepatocellular carcinoma.
Cucchetti A; Trevisani F; Pecorelli A; Erroi V; Farinati F; Ciccarese F; Rapaccini GL; Di Marco M; Caturelli E; Giannini EG; Zoli M; Borzio F; Cabibbo G; Felder M; Gasbarrini A; Sacco R; Foschi FG; Missale G; Morisco F; Baroni GS; Virdone R; Bernardi M; Pinna AD;
J Hepatol; 2014 Aug; 61(2):333-41. PubMed ID: 24717522
[TBL] [Abstract][Full Text] [Related]
5. Intensity of surveillance for hepatocellular carcinoma determines survival in patients at risk in a hepatitis B-endemic area.
Kim HY; Nam JY; Lee JH; Lee HA; Chang Y; Lee HY; Cho H; Lee DH; Cho YY; Cho EJ; Yu SJ; Lee JM; Kim YJ; Yoon JH
Aliment Pharmacol Ther; 2018 Jun; 47(11):1490-1501. PubMed ID: 29611209
[TBL] [Abstract][Full Text] [Related]
6. Surveillance program for early detection of hepatocellular carcinoma in Japan: results of specialized department of liver disease.
Ando E; Kuromatsu R; Tanaka M; Takada A; Fukushima N; Sumie S; Nagaoka S; Akiyoshi J; Inoue K; Torimura T; Kumashiro R; Ueno T; Sata M
J Clin Gastroenterol; 2006; 40(10):942-8. PubMed ID: 17063116
[TBL] [Abstract][Full Text] [Related]
7. Growth rate of early-stage hepatocellular carcinoma in patients with chronic liver disease.
An C; Choi YA; Choi D; Paik YH; Ahn SH; Kim MJ; Paik SW; Han KH; Park MS
Clin Mol Hepatol; 2015 Sep; 21(3):279-86. PubMed ID: 26523271
[TBL] [Abstract][Full Text] [Related]
8. Surveillance of hepatocellular carcinoma in patients with hepatitis C virus infection may improve patient survival.
Tanaka H; Nouso K; Kobashi H; Kobayashi Y; Nakamura S; Miyake Y; Ohnishi H; Miyoshi K; Iwado S; Iwasaki Y; Sakaguchi K; Shiratori Y
Liver Int; 2006 Jun; 26(5):543-51. PubMed ID: 16761998
[TBL] [Abstract][Full Text] [Related]
9. Survival of hepatocellular carcinoma patients may be improved in surveillance interval not more than 6 months compared with more than 6 months: a 15-year prospective study.
Han KH; Kim DY; Park JY; Ahn SH; Kim J; Kim SU; Kim JK; Lee KS; Chon CY
J Clin Gastroenterol; 2013 Jul; 47(6):538-44. PubMed ID: 23340065
[TBL] [Abstract][Full Text] [Related]
10. Impact of disease stage and aetiology on survival in hepatocellular carcinoma: implications for surveillance.
Johnson P; Berhane S; Kagebayashi C; Satomura S; Teng M; Fox R; Yeo W; Mo F; Lai P; Chan SL; Tada T; Toyoda H; Kumada T
Br J Cancer; 2017 Feb; 116(4):441-447. PubMed ID: 28081537
[TBL] [Abstract][Full Text] [Related]
11. Comparison between alcohol- and hepatitis C virus-related hepatocellular carcinoma: clinical presentation, treatment and outcome.
Bucci L; Garuti F; Camelli V; Lenzi B; Farinati F; Giannini EG; Ciccarese F; Piscaglia F; Rapaccini GL; Di Marco M; Caturelli E; Zoli M; Borzio F; Sacco R; Maida M; Felder M; Morisco F; Gasbarrini A; Gemini S; Foschi FG; Missale G; Masotto A; Affronti A; Bernardi M; Trevisani F; ;
Aliment Pharmacol Ther; 2016 Feb; 43(3):385-99. PubMed ID: 26662476
[TBL] [Abstract][Full Text] [Related]
12. Surveillance for early diagnosis of hepatocellular carcinoma: is it effective in intermediate/advanced cirrhosis?
Trevisani F; Santi V; Gramenzi A; Di Nolfo MA; Del Poggio P; Benvegnù L; Rapaccini G; Farinati F; Zoli M; Borzio F; Giannini EG; Caturelli E; Bernardi M;
Am J Gastroenterol; 2007 Nov; 102(11):2448-57; quiz 2458. PubMed ID: 17617210
[TBL] [Abstract][Full Text] [Related]
13. Semiannual surveillance is superior to annual surveillance for the detection of early hepatocellular carcinoma and patient survival.
Santi V; Trevisani F; Gramenzi A; Grignaschi A; Mirici-Cappa F; Del Poggio P; Di Nolfo MA; Benvegnù L; Farinati F; Zoli M; Giannini EG; Borzio F; Caturelli E; Chiaramonte M; Bernardi M;
J Hepatol; 2010 Aug; 53(2):291-7. PubMed ID: 20483497
[TBL] [Abstract][Full Text] [Related]
14. Compliance With Hepatocellular Carcinoma Surveillance Guidelines Associated With Increased Lead-Time Adjusted Survival of Patients With Compensated Viral Cirrhosis: A Multi-Center Cohort Study.
Costentin CE; Layese R; Bourcier V; Cagnot C; Marcellin P; Guyader D; Pol S; Larrey D; De Lédinghen V; Ouzan D; Zoulim F; Roulot D; Tran A; Bronowicki JP; Zarski JP; Riachi G; Calès P; Péron JM; Alric L; Bourlière M; Mathurin P; Blanc JF; Abergel A; Serfaty L; Mallat A; Grangé JD; Attali P; Bacq Y; Wartelle C; Dao T; Thabut D; Pilette C; Silvain C; Christidis C; Nguyen-Khac E; Bernard-Chabert B; Zucman D; Di Martino V; Sutton A; Letouzé E; Imbeaud S; Zucman-Rossi J; Audureau E; Roudot-Thoraval F; Nahon P;
Gastroenterology; 2018 Aug; 155(2):431-442.e10. PubMed ID: 29729258
[TBL] [Abstract][Full Text] [Related]
15. Impact of etiology of cirrhosis on the survival of patients diagnosed with hepatocellular carcinoma during surveillance.
Trevisani F; Magini G; Santi V; Morselli-Labate AM; Cantarini MC; Di Nolfo MA; Del Poggio P; Benvegnù L; Rapaccini G; Farinati F; Zoli M; Borzio F; Giannini EG; Caturelli E; Bernardi M;
Am J Gastroenterol; 2007 May; 102(5):1022-31. PubMed ID: 17313497
[TBL] [Abstract][Full Text] [Related]
16. Radiofrequency ablation of hepatocellular carcinoma in difficult locations: Strategies and long-term outcomes.
Yang W; Yan K; Wu GX; Wu W; Fu Y; Lee JC; Zhang ZY; Wang S; Chen MH
World J Gastroenterol; 2015 Feb; 21(5):1554-66. PubMed ID: 25663774
[TBL] [Abstract][Full Text] [Related]
17. Surveillance for hepatocellular carcinoma improves survival in Asian-American patients with hepatitis B: results from a community-based clinic.
Tong MJ; Sun HE; Hsien C; Lu DS
Dig Dis Sci; 2010 Mar; 55(3):826-35. PubMed ID: 19960258
[TBL] [Abstract][Full Text] [Related]
18. Incidence and risk factors associated with hepatocellular carcinoma surveillance failure.
Mancebo A; Varela M; González-Diéguez ML; Navascués CA; Cadahía V; Mesa-Álvarez A; Rodrigo L; Rodríguez M
J Gastroenterol Hepatol; 2018 Aug; 33(8):1524-1529. PubMed ID: 29384236
[TBL] [Abstract][Full Text] [Related]
19. Surveillance programme of cirrhotic patients for early diagnosis and treatment of hepatocellular carcinoma: a cost effectiveness analysis.
Bolondi L; Sofia S; Siringo S; Gaiani S; Casali A; Zironi G; Piscaglia F; Gramantieri L; Zanetti M; Sherman M
Gut; 2001 Feb; 48(2):251-9. PubMed ID: 11156649
[TBL] [Abstract][Full Text] [Related]
20. Hepatocellular carcinoma screening and surveillance in 2293 chronic hepatitis B patients in an endemic area.
Ungtrakul T; Mahidol C; Chun-On P; Laohapand C; Siripongsakun S; Worakitsitisatorn A; Vidhayakorn S; Boonchuay W; Dechma J; Sornsamdang G; Soonklang K; Sriprayoon T; Tanwandee T; Auewarakul CU
World J Gastroenterol; 2016 Sep; 22(34):7806-12. PubMed ID: 27678364
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
